- Home
- BCTX
as 11-21-2025 3:11pm EST
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
| Founded: | 2014 | Country: | Canada |
| Employees: | N/A | City: | WEST VANCOUVER |
| Market Cap: | 18.5M | IPO Year: | N/A |
| Target Price: | $40.00 | AVG Volume (30 days): | 45.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -62.19 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.00 - $190.50 | Next Earning Date: | 12-15-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest BriaCell Therapeutics Corp. News
BCTX Breaking Stock News: Dive into BCTX Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics
MT Newswires
3 days ago
BriaCell Therapeutics Selected to Present Four Posters at Breast Cancer Symposium
GlobeNewswire
4 days ago
BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025
GlobeNewswire
15 days ago
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025
MT Newswires
18 days ago
BriaCell Therapeutics to Present Latest Anti-cancer Data of Bria-OTS+
Zacks
25 days ago
Zacks.com featured highlights include Groupon, BriaCell Therapeutics and InnovAge Holding
Zacks
25 days ago
Top 3 Earnings Acceleration Buys for November
MT Newswires
a month ago
BriaCell Receives Data Safety Monitoring Board OK to Continue Phase 3 Metastatic Breast Cancer Study
Compare BCTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BCTX BriaCell Therapeutics Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.